I accept receiving promo codes and other educational info from this company.
Get My Code
Click on any of the term papers to read a brief synopsis of the research paper. The essay synopsis includes the number of pages and sources cited in the paper.
8 pages in length. Not unlike other industries that rely upon a positive bottom line to remain competitive, the pharmaceutical industry is faced with ever-mounting competition in this day of high medical costs and escalating insurance premiums. Staying within the industry edge is as much of a concern for the pharmaceutical companies as it is for any other conglomerate. The writer discusses pricing as it relates to the pharmaceutical industry. Bibliography lists 7 sources.
5 pages in length. Marketing will become one of the primary focal points as a means by which the pharmaceutical industry can effectively overcome the barriers of government-imposed price controls. Business and marketing strategies for the pharmaceutical industry in general will reflect a need for simplicity and sensibility in order to effectively address major needs. The writer discusses the potential impact of government-imposed price controls upon the pharmaceutical industry. Bibliography lists 7 sources.
A 14 page discussion of the pharmaceutical industry and the reception generic drugs have within that industry. This paper presents the thesis that it is both ethical and legal for pharmaceutical companies to interfere with or to delay generic drugs being released into the marketplace. Bibliography lists 6 sources.
A 4 page paper that reports a brief history of the generic pharmaceutical industry. Examples of generic companies are provided and the writer comments on the effect of the generic companies on the pharmaceutical industry. Bibliography lists 9 sources.
This 4 page paper is written in two parts. Using GlaxoSmithKline as example the first part of the paper discusses the key to success factors for pharmaceutical companies and which of the success factors can be transferred to generic drug manufacturing companies. The second part of the paper discusses what lessons can be drawn from the development of sustainable competitive advantage for other companies outside the pharmaceutical industry. The bibliography cites 3 sources.